BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsatsakis A, Calina D, Falzone L, Petrakis D, Mitrut R, Siokas V, Pennisi M, Lanza G, Libra M, Doukas SG, Doukas PG, Kavali L, Bukhari A, Gadiparthi C, Vageli DP, Kofteridis DP, Spandidos DA, Paoliello MMB, Aschner M, Docea AO. SARS-CoV-2 pathophysiology and its clinical implications: An integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020;146:111769. [PMID: 32979398 DOI: 10.1016/j.fct.2020.111769] [Cited by in Crossref: 80] [Cited by in F6Publishing: 73] [Article Influence: 40.0] [Reference Citation Analysis]
Number Citing Articles
1 Askari G, Rouhani MH, Sattari M, Wu F. Prediction of Length of Hospital Stay of COVID-19 Patients Using Gradient Boosting Decision Tree. International Journal of Biomaterials 2022;2022:1-4. [DOI: 10.1155/2022/6474883] [Reference Citation Analysis]
2 Asghar K, Abu Bakar M, Ashfaq S, Alvi AM, Shafiq W, Azmat U, Siddiqi AI, Farooq A, Raza R, Siddique K. COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management. Front Oncol 2022;12:922579. [DOI: 10.3389/fonc.2022.922579] [Reference Citation Analysis]
3 Ioannou M, Zacharouli K, Doukas SG, Diamantidis MD, Tsangari V, Karakousis K, Koukoulis GK, Vageli DP. Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review. J Mol Histol 2022. [PMID: 35699822 DOI: 10.1007/s10735-022-10088-4] [Reference Citation Analysis]
4 Covantes-rosales CE, Barajas-carrillo VW, Girón-pérez DA, Toledo-ibarra GA, Díaz-reséndiz KJG, Navidad-murrieta MS, Ventura-ramón GH, Pulido-muñoz ME, Mercado-salgado U, Ojeda-durán AJ, Argüero-fonseca A, Girón-pérez MI. Comparative Analysis of Age, Sex, and Viral Load in Outpatients during the Four Waves of SARS-CoV-2 in A Mexican Medium-Sized City. IJERPH 2022;19:5719. [DOI: 10.3390/ijerph19095719] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Barajas-Carrillo VW, Covantes-Rosales CE, Zambrano-Soria M, Castillo-Pacheco LA, Girón-Pérez DA, Mercado-Salgado U, Ojeda-Durán AJ, Vázquez-Pulido EY, Girón-Pérez MI. SARS-CoV-2 Transmission Risk Model in an Urban Area of Mexico, Based on GIS Analysis and Viral Load. Int J Environ Res Public Health 2022;19:3840. [PMID: 35409524 DOI: 10.3390/ijerph19073840] [Reference Citation Analysis]
6 Stefanou M, Palaiodimou L, Bakola E, Smyrnis N, Papadopoulou M, Paraskevas GP, Rizos E, Boutati E, Grigoriadis N, Krogias C, Giannopoulos S, Tsiodras S, Gaga M, Tsivgoulis G. Neurological manifestations of long-COVID syndrome: a narrative review. Therapeutic Advances in Chronic Disease 2022;13:204062232210768. [DOI: 10.1177/20406223221076890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 14.0] [Reference Citation Analysis]
7 Rosca A, Balcaen T, Lanoix J, Michaud A, Moyet J, Marcq I, Schmit J, Bloch F, Deschasse G. Mortality risk and antibiotic use for COVID-19 in hospitalized patients over 80. Biomedicine & Pharmacotherapy 2022;146:112481. [DOI: 10.1016/j.biopha.2021.112481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Al-qerem W, Hammad A, Alsajri AH, Al-hishma SW, Ling J, Mosleh R. COVID-19 Vaccination Acceptance and Its Associated Factors Among the Iraqi Population: A Cross Sectional Study. PPA 2022;Volume 16:307-19. [DOI: 10.2147/ppa.s350917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 El-Shabasy RM, Nayel MA, Taher MM, Abdelmonem R, Shoueir KR, Kenawy ER. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int J Biol Macromol 2022;204:161-8. [PMID: 35074332 DOI: 10.1016/j.ijbiomac.2022.01.118] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 21.0] [Reference Citation Analysis]
10 Chable-bessia C, Boullé C, Neyret A, Swain J, Hénaut M, Merida P, Gros N, Makinson A, Lyonnais S, Chesnais C, Muriaux D. Low Selectivity Indices of Ivermectin and Macrocyclic Lactones on SARS-CoV-2 Replication In Vitro. COVID 2022;2:60-75. [DOI: 10.3390/covid2010005] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Efstathiou V, Stefanou MI, Siafakas N, Makris M, Tsivgoulis G, Zoumpourlis V, Spandidos DA, Smyrnis N, Rizos E. Suicidality and COVID-19: Suicidal ideation, suicidal behaviors and completed suicides amidst the COVID-19 pandemic (Review). Exp Ther Med 2022;23:107. [PMID: 34976149 DOI: 10.3892/etm.2021.11030] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kaur R, Singh S, Singh TG, Sood P, Robert J. Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination. Inflammopharmacology 2022. [PMID: 34981320 DOI: 10.1007/s10787-021-00904-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lak E, Mohammadi MJ, Yousefi H. Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients. Toxicol Rep 2022;9:46-52. [PMID: 34934636 DOI: 10.1016/j.toxrep.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Pleszkó A, Pauleczki A, Óvári I, Óvári J, Hauser P. Isolated Hallucination as a Consequence of SARS-CoV-2 Infection in a 10-year-old Child. Clin Child Psychol Psychiatry 2021;:13591045211061805. [PMID: 34937405 DOI: 10.1177/13591045211061805] [Reference Citation Analysis]
15 P N, R N, B V, S R, A S. COVID-19: Invasion, pathogenesis and possible cure - A review. J Virol Methods 2022;300:114434. [PMID: 34919978 DOI: 10.1016/j.jviromet.2021.114434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Serebrennikova KV, Byzova NA, Zherdev AV, Khlebtsov NG, Khlebtsov BN, Biketov SF, Dzantiev BB. Lateral Flow Immunoassay of SARS-CoV-2 Antigen with SERS-Based Registration: Development and Comparison with Traditional Immunoassays. Biosensors (Basel) 2021;11:510. [PMID: 34940267 DOI: 10.3390/bios11120510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Senia P, Vella F, Mucci N, Dounias G, Trovato A, Marconi A, Ledda C, Rapisarda V, Vitale E. Survey on COVID-19-related mortality associated with occupational infection during the first phase of the pandemic: A systematic review. Exp Ther Med 2022;23:10. [PMID: 34815762 DOI: 10.3892/etm.2021.10932] [Reference Citation Analysis]
18 Chan KG, Ang GY, Yu CY, Yean CY. Harnessing CRISPR-Cas to Combat COVID-19: From Diagnostics to Therapeutics. Life (Basel) 2021;11:1210. [PMID: 34833086 DOI: 10.3390/life11111210] [Reference Citation Analysis]
19 García S, Cuatepotzo-Burgos FM, Toledo-Lozano CG, Balderrama-Soto A, Alcaraz-Estrada SL, Montiel-López L, De la Vega-Bravo AH, Mondragón-Terán P, Santosbeña-Lagunes M, Escarela-Serrano M, Rodríguez-Martínez CM, Méndez-Vidrio MDC, Muñoz-López S, Merino-Rajme JA, Rodríguez-Briseño RA, Cerda-Téllez F, Coral-Vázquez RM, Sauri-Suárez S, Quiñonez-Aguilar S, Pineda-Juárez JA, Suárez-Cuenca JA. Neurological Manifestations and Outcomes in a Retrospective Cohort of Mexican Inpatients with SARS-CoV-2 Pneumonia: Design of a Risk Profile. Healthcare (Basel) 2021;9:1501. [PMID: 34828547 DOI: 10.3390/healthcare9111501] [Reference Citation Analysis]
20 Raj K, Chandna S, Doukas SG, Watts A, Jyotheeswara Pillai K, Anandam A, Singh D, Nagarakanti R, Sankaramangalam K. Combined Use of Wells Scores and D-dimer Levels for the Diagnosis of Deep Vein Thrombosis and Pulmonary Embolism in COVID-19: A Retrospective Cohort Study. Cureus 2021;13:e17687. [PMID: 34650862 DOI: 10.7759/cureus.17687] [Reference Citation Analysis]
21 Izadmehr S, Lundon DJ, Mohamed N, Katims A, Patel V, Eilender B, Mehrazin R, Badani KK, Sfakianos JP, Tsao CK, Wiklund P, Oh WK, Cordon-Cardo C, Tewari AK, Galsky MD, Kyprianou N. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic. Front Oncol 2021;11:734963. [PMID: 34646777 DOI: 10.3389/fonc.2021.734963] [Reference Citation Analysis]
22 Liu Y, Liu S, Qin Y, Zhao L, Li Y, Zhou C, Chen W. Does prior exposure to immune checkpoint inhibitors treatment affect incidence and mortality of COVID-19 among the cancer patients: The systematic review and meta-analysis. Int Immunopharmacol 2021;101:108242. [PMID: 34688136 DOI: 10.1016/j.intimp.2021.108242] [Reference Citation Analysis]
23 Russo G, Di Salvatore V, Sgroi G, Parasiliti Palumbo GA, Reche PA, Pappalardo F. A multi-step and multi-scale bioinformatic protocol to investigate potential SARS-CoV-2 vaccine targets. Brief Bioinform 2021:bbab403. [PMID: 34607353 DOI: 10.1093/bib/bbab403] [Reference Citation Analysis]
24 Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, Polyakova IV, Bedretdinova ZS, Belikina DV, Lavrenyuk AA, Fomin IV. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med 2021;13:16-24. [PMID: 34603760 DOI: 10.17691/stm2021.13.4.02] [Reference Citation Analysis]
25 Tsatsakis A, Vakonaki E, Tzatzarakis M, Flamourakis M, Nikolouzakis TK, Poulas K, Papazoglou G, Hatzidaki E, Papanikolaou NC, Drakoulis N, Iliaki E, Goulielmos GN, Kallionakis M, Lazopoulos G, Kteniadakis S, Alegkakis A, Farsalinos K, Spandidos DA. Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals. Int J Mol Med 2021;48:200. [PMID: 34515322 DOI: 10.3892/ijmm.2021.5033] [Reference Citation Analysis]
26 Pham QT, Le XTT, Phan TC, Nguyen QN, Ta NKT, Nguyen AN, Nguyen TT, Nguyen QT, Le HT, Luong AM, Koh D, Hoang MT, Pham HQ, Vu LG, Nguyen TH, Tran BX, Latkin CA, Ho CSH, Ho RCM. Impacts of COVID-19 on the Life and Work of Healthcare Workers During the Nationwide Partial Lockdown in Vietnam. Front Psychol 2021;12:563193. [PMID: 34489769 DOI: 10.3389/fpsyg.2021.563193] [Reference Citation Analysis]
27 Calina D, Hernández AF, Hartung T, Egorov AM, Izotov BN, Nikolouzakis TK, Tsatsakis A, Vlachoyiannopoulos PG, Docea AO. Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2. Life (Basel) 2021;11:907. [PMID: 34575056 DOI: 10.3390/life11090907] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Li Q, Xia Y, Liao D, Nie H, Zhang M, Wang T, Liao J, Xia Q. Dual-target one-step nested PCR for sensitive detection of SARS-CoV-2 nucleic acids. Prep Biochem Biotechnol 2021;:1-7. [PMID: 34410212 DOI: 10.1080/10826068.2021.1964084] [Reference Citation Analysis]
29 Shafiee S, Cegolon L, Khafaei M, Gholami N, Zhao S, Khalesi N, Moosavian H, Fathi S, Izadi M, Ghadian A, Javanbakht M, Javanbakht A, Akhavan-Sigari R. Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19. Cancer Cell Int 2021;21:431. [PMID: 34399734 DOI: 10.1186/s12935-021-02129-x] [Reference Citation Analysis]
30 Fedorov V, Kholina E, Khruschev S, Kovalenko I, Rubin A, Strakhovskaya M. What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. Viruses 2021;13:1615. [PMID: 34452480 DOI: 10.3390/v13081615] [Reference Citation Analysis]
31 Darweesh O, Abdulrazzaq GM, Al-Zidan RN, Bebane P, Merkhan M, Aldabbagh R, AlOmari N. Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq. Curr Pharmacol Rep 2021;:1-8. [PMID: 34377628 DOI: 10.1007/s40495-021-00262-9] [Reference Citation Analysis]
32 Olak AS, Susuki AM, Kanashiro M, Paoliello MMB, Aschner M, Urbano MR. Risk factors associated with COVID-19-induced death in patients hospitalized in intensive care units (ICUs) in a city in Southern Brazil. Toxicol Rep 2021;8:1565-8. [PMID: 34377679 DOI: 10.1016/j.toxrep.2021.07.020] [Reference Citation Analysis]
33 Alyasseri ZAA, Al-Betar MA, Doush IA, Awadallah MA, Abasi AK, Makhadmeh SN, Alomari OA, Abdulkareem KH, Adam A, Damasevicius R, Mohammed MA, Zitar RA. Review on COVID-19 diagnosis models based on machine learning and deep learning approaches. Expert Syst 2021;:e12759. [PMID: 34511689 DOI: 10.1111/exsy.12759] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
34 Gugliandolo A, Chiricosta L, Calcaterra V, Biasin M, Cappelletti G, Carelli S, Zuccotti G, Avanzini MA, Bramanti P, Pelizzo G, Mazzon E. SARS-CoV-2 Infected Pediatric Cerebral Cortical Neurons: Transcriptomic Analysis and Potential Role of Toll-like Receptors in Pathogenesis. Int J Mol Sci 2021;22:8059. [PMID: 34360824 DOI: 10.3390/ijms22158059] [Reference Citation Analysis]
35 Jearanaiwitayakul T, Seesen M, Chawengkirttikul R, Limthongkul J, Apichirapokey S, Sapsutthipas S, Phumiamorn S, Sunintaboon P, Ubol S. Intranasal Administration of RBD Nanoparticles Confers Induction of Mucosal and Systemic Immunity against SARS-CoV-2. Vaccines (Basel) 2021;9:768. [PMID: 34358183 DOI: 10.3390/vaccines9070768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Ramezanpour M, Bolt H, Hon K, Bouras GS, Psaltis AJ, Wormald PJ, Vreugde S. Cytokine-Induced Modulation of SARS-CoV2 Receptor Expression in Primary Human Nasal Epithelial Cells. Pathogens 2021;10:848. [PMID: 34357998 DOI: 10.3390/pathogens10070848] [Reference Citation Analysis]
37 Pezeshki A, Vaezi A, Nematollahi P. Blood cell morphology and COVID-19 clinical course, severity, and outcome. J Hematop 2021;:1-8. [PMID: 34249171 DOI: 10.1007/s12308-021-00459-3] [Reference Citation Analysis]
38 Ali MR, Hasan MA, Rahman MS, Billah M, Karmakar S, Shimu AS, Hossain MF, Maruf MMH, Rahman MS, Saju MSR, Hasan MR, Acharjee UK, Hasan MF. Clinical manifestations and socio-demographic status of COVID-19 patients during the second-wave of pandemic: A Bangladeshi experience. J Infect Public Health 2021:S1876-0341(21)00177-5. [PMID: 34215560 DOI: 10.1016/j.jiph.2021.06.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Musso N, Falzone L, Stracquadanio S, Bongiorno D, Salerno M, Esposito M, Sessa F, Libra M, Stefani S, Pomara C. Post-Mortem Detection of SARS-CoV-2 RNA in Long-Buried Lung Samples. Diagnostics (Basel) 2021;11:1158. [PMID: 34202678 DOI: 10.3390/diagnostics11071158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Milovanovic B, Djajic V, Bajic D, Djokovic A, Krajnovic T, Jovanovic S, Verhaz A, Kovacevic P, Ostojic M. Assessment of Autonomic Nervous System Dysfunction in the Early Phase of Infection With SARS-CoV-2 Virus. Front Neurosci 2021;15:640835. [PMID: 34234638 DOI: 10.3389/fnins.2021.640835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Falzone L, Scandurra G, Lombardo V, Gattuso G, Lavoro A, Distefano AB, Scibilia G, Scollo P. A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer (Review). Int J Oncol 2021;59:53. [PMID: 34132354 DOI: 10.3892/ijo.2021.5233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Al-Zakhari R, Atere M, Lim W, Abdulrahman M, Akhtar S, Sheets N, Joyce T, Stefanishina V, Appiah-Kubi E, Owusu-Antwi P, Nfonoyim J, Grodman R, Rotatori F. Corrected QT Interval Prolongation, Elevated Troponin, and Mortality in Hospitalized COVID-19 Patients. Cardiol Res 2021;12:258-64. [PMID: 34349868 DOI: 10.14740/cr1276] [Reference Citation Analysis]
43 Zolotovskaia IA, Shatskaia PR, Davydkin IL, Shavlovskaya OA. [Post-COVID-19 asthenic syndrome]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:25-30. [PMID: 34037351 DOI: 10.17116/jnevro202112104125] [Reference Citation Analysis]
44 Romero-Duarte Á, Rivera-Izquierdo M, Guerrero-Fernández de Alba I, Pérez-Contreras M, Fernández-Martínez NF, Ruiz-Montero R, Serrano-Ortiz Á, González-Serna RO, Salcedo-Leal I, Jiménez-Mejías E, Cárdenas-Cruz A. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med 2021;19:129. [PMID: 34011359 DOI: 10.1186/s12916-021-02003-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
45 Asghar K, Abu Bakar M, Akram MJ, Farooq A, Siddique K, Rana IA, Ali J, Rashid MU, Khan AA, Loya A. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Front Oncol 2021;11:655634. [PMID: 34094950 DOI: 10.3389/fonc.2021.655634] [Reference Citation Analysis]
46 Pucci F, Rooman M. Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro. Viruses 2021;13:935. [PMID: 34070055 DOI: 10.3390/v13050935] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Palazzuoli A, Giustozzi M, Ruocco G, Tramonte F, Gronda E, Agnelli G. Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence. Life (Basel) 2021;11:395. [PMID: 33925334 DOI: 10.3390/life11050395] [Reference Citation Analysis]
48 Hernández AF, Calina D, Poulas K, Docea AO, Tsatsakis AM. Safety of COVID-19 vaccines administered in the EU: Should we be concerned? Toxicol Rep 2021;8:871-9. [PMID: 33898273 DOI: 10.1016/j.toxrep.2021.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
49 Skalny AV, Timashev PS, Aschner M, Aaseth J, Chernova LN, Belyaev VE, Grabeklis AR, Notova SV, Lobinski R, Tsatsakis A, Svistunov AA, Fomin VV, Tinkov AA, Glybochko PV. Serum Zinc, Copper, and Other Biometals Are Associated with COVID-19 Severity Markers. Metabolites 2021;11:244. [PMID: 33920813 DOI: 10.3390/metabo11040244] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Falzone L, Gattuso G, Tsatsakis A, Spandidos DA, Libra M. Current and innovative methods for the diagnosis of COVID‑19 infection (Review). Int J Mol Med 2021;47:100. [PMID: 33846767 DOI: 10.3892/ijmm.2021.4933] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
51 Vinceti M, Filippini T, Rothman KJ, Di Federico S, Orsini N. SARS-CoV-2 infection incidence during the first and second COVID-19 waves in Italy. Environ Res 2021;197:111097. [PMID: 33811866 DOI: 10.1016/j.envres.2021.111097] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
52 El-megharbel SM, Alsawat M, Al-salmi FA, Hamza RZ. Utilizing of (Zinc Oxide Nano-Spray) for Disinfection against “SARS-CoV-2” and Testing Its Biological Effectiveness on Some Biochemical Parameters during (COVID-19 Pandemic)—”ZnO Nanoparticles Have Antiviral Activity against (SARS-CoV-2)”. Coatings 2021;11:388. [DOI: 10.3390/coatings11040388] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 17.0] [Reference Citation Analysis]
53 Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å. COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway. Front Oncol 2021;11:652535. [PMID: 33842366 DOI: 10.3389/fonc.2021.652535] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
54 Calina D, Hartung T, Mardare I, Mitroi M, Poulas K, Tsatsakis A, Rogoveanu I, Docea AO. COVID-19 pandemic and alcohol consumption: Impacts and interconnections. Toxicol Rep 2021;8:529-35. [PMID: 33723508 DOI: 10.1016/j.toxrep.2021.03.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
55 Salman AA, Waheed MH, Ali-Abdulsahib AA, Atwan ZW. Low type I interferon response in COVID-19 patients: Interferon response may be a potential treatment for COVID-19. Biomed Rep 2021;14:43. [PMID: 33786172 DOI: 10.3892/br.2021.1419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
56 Souchelnytskyi S, Nera A, Souchelnytskyi N. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Sci Rep 2021;11:5228. [PMID: 33664395 DOI: 10.1038/s41598-021-84780-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Siddiqui R, Mungroo MR, Khan NA. SARS-CoV-2 invasion of the central nervous: a brief review. Hosp Pract (1995) 2021;49:157-63. [PMID: 33554684 DOI: 10.1080/21548331.2021.1887677] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Qu JY, Xie HT, Zhang MC. Evidence of SARS-CoV-2 Transmission Through the Ocular Route. Clin Ophthalmol 2021;15:687-96. [PMID: 33658750 DOI: 10.2147/OPTH.S295283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415. [PMID: 33546463 DOI: 10.3390/ijerph18041415] [Reference Citation Analysis]
60 Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415. [PMID: 33546463 DOI: 10.3390/ijerph18041415] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 40.0] [Reference Citation Analysis]
61 Wang X, He Z, Zhao X. Immunoregulatory therapy strategies that target cytokine storms in patients with COVID-19 (Review). Exp Ther Med 2021;21:319. [PMID: 33732292 DOI: 10.3892/etm.2021.9750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Gelemanović A, Vidović T, Stepanić V, Trajković K. Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach. Pharmaceuticals (Basel) 2021;14:87. [PMID: 33504008 DOI: 10.3390/ph14020087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Lagoumintzis G, Chasapis CT, Alexandris N, Kouretas D, Tzartos S, Eliopoulos E, Farsalinos K, Poulas K. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins. Food Chem Toxicol 2021;149:112009. [PMID: 33503469 DOI: 10.1016/j.fct.2021.112009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 10.0] [Reference Citation Analysis]
64 Islam MT, Quispe C, Martorell M, Docea AO, Salehi B, Calina D, Reiner Ž, Sharifi-rad J. Dietary supplements, vitamins and minerals as potential interventions against viruses: Perspectives for COVID-19. International Journal for Vitamin and Nutrition Research. [DOI: 10.1024/0300-9831/a000694] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
65 Cerino P, Coppola A, Volzone P, Pizzolante A, Pierri B, Atripaldi L, Zollo M, Capasso M, Ascierto PA, Triassi M, Brambilla G, Perrella A, Bruzzese D, Buonerba C. Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study. Future Sci OA 2021;7:FSO673. [PMID: 33815819 DOI: 10.2144/fsoa-2020-0203] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
66 Mohandas S, Yadav PD, Shete-Aich A, Abraham P, Vadrevu KM, Sapkal G, Mote C, Nyayanit D, Gupta N, Srinivas VK, Kadam M, Kumar A, Majumdar T, Jain R, Deshpande G, Patil S, Sarkale P, Patil D, Ella R, Prasad SD, Sharma S, Ella KM, Panda S, Bhargava B. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience 2021;24:102054. [PMID: 33521604 DOI: 10.1016/j.isci.2021.102054] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
67 Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B, Zhao Z, Jin S. The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. Int J Environ Res Public Health 2021;18:E284. [PMID: 33401657 DOI: 10.3390/ijerph18010284] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
68 Alexandris N, Lagoumintzis G, Chasapis CT, Leonidas DD, Papadopoulos GE, Tzartos SJ, Tsatsakis A, Eliopoulos E, Poulas K, Farsalinos K. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 2021;8:73-83. [PMID: 33425684 DOI: 10.1016/j.toxrep.2020.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
69 Yu S, Yu M. Severe Acute Respiratory Syndrome Coronavirus 2-Induced Neurological Complications. Front Cell Dev Biol 2020;8:605972. [PMID: 33363165 DOI: 10.3389/fcell.2020.605972] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Farsalinos K, Poulas K, Kouretas D, Vantarakis A, Leotsinidis M, Kouvelas D, Docea AO, Kostoff R, Gerotziafas GT, Antoniou MN, Polosa R, Barbouni A, Yiakoumaki V, Giannouchos TV, Bagos PG, Lazopoulos G, Izotov BN, Tutelyan VA, Aschner M, Hartung T, Wallace HM, Carvalho F, Domingo JL, Tsatsakis A. Improved strategies to counter the COVID-19 pandemic: Lockdowns vs. primary and community healthcare. Toxicol Rep 2021;8:1-9. [PMID: 33294384 DOI: 10.1016/j.toxrep.2020.12.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
71 Ramírez-Salinas GL, Martínez-Archundia M, Correa-Basurto J, García-Machorro J. Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study. Molecules 2020;25:E5615. [PMID: 33260370 DOI: 10.3390/molecules25235615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
72 Quagliariello V, Bonelli A, Caronna A, Conforti G, Iovine M, Carbone A, Berretta M, Botti G, Maurea N. SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients. Cancers (Basel) 2020;12:E3316. [PMID: 33182653 DOI: 10.3390/cancers12113316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
73 Kostoff RN, Kanduc D, Porter AL, Shoenfeld Y, Calina D, Briggs MB, Spandidos DA, Tsatsakis A. Vaccine- and natural infection-induced mechanisms that could modulate vaccine safety. Toxicol Rep 2020;7:1448-58. [PMID: 33110761 DOI: 10.1016/j.toxrep.2020.10.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]